Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SOURCE HLTH CARE S&P US SECTOR UCITS ETF

+ Add to Watchlist

XLVS:LN

297.4450 USD 1.0700 0.36%

As of 11:35:05 ET on 01/30/2015.

Snapshot for SOURCE HLTH CARE S&P US SECTOR UCITS ETF (XLVS)

Open: 299.5000 High - Low: 299.9000 - 297.4450 Primary Exchange: London
Volume: 1,378 52-Week Range: 233.0400 - 305.3300 Beta vs SPSUHCN: 0.9599

ETF Chart for XLVS

No chart data available.
  • XLVS:LN 297.4450
  • 1D
  • 1M
  • 1Y
296.3750
Interactive XLVS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XLVS

Source Health Care S&P US Select Sector UCITS ETF is a UCITS compliant exchange- traded investment fund incorporated in Ireland. The objective of the fund is to track the performance of the S&P Select Sector Capped 20% (Health Care) Net Total Return Index.

Inception Date: 2010-01-05 Telephone: +44-20-3370-1100
Managers: -
Web Site: www.source.info

Fundamentals for XLVS

NAV (on 2015-01-29) 300.2323
Assets (M) (on 2015-01-29) 117.7109
Shares out (M) 0.39
Market Cap (M) 116.62
% Premium -1.28
Average 52-Week % Premium 0.0175
Fund Leveraged N

Dividends for XLVS

No dividends reported

Performance for XLVS

1-Month +0.22% 1-Year +25.29%
3-Month +3.50% 3-Year +26.19%
Year To Date +0.22% 5-Year +18.48%
Expense Ratio 0.30

Top Fund Holdings for XLVS

Filing Date: 12/31/2014
Name Position Value % of Total
Johnson & Johnson 111,496 11,659,120 11.287%
Pfizer Inc 250,972 7,817,765 7.568%
Merck & Co Inc 113,558 6,448,942 6.243%
Gilead Sciences Inc 60,094 5,664,462 5.484%
Amgen Inc 30,299 4,826,402 4.672%
AbbVie Inc 63,464 4,153,077 4.021%
Bristol-Myers Squibb Co 66,073 3,900,311 3.776%
UnitedHealth Group Inc 38,231 3,864,769 3.741%
Celgene Corp 31,814 3,558,766 3.445%
Biogen Idec Inc 9,407 3,193,094 3.091%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil